window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 10, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Precision medicine

  • Artificial Intelligence,Clinical Development,Genomics and sequencing,Obesity,Precision medicine,Technology and platforms

    23andMe study links genetics to GLP-1 weight loss outcomes and side effects

    This Nature-published study from the 23andMe Research Institute identifies genetic [...]

    April 9, 2026
  • Clinical Development,Infectious Diseases,Patient Centricity,Precision medicine

    ViiV Healthcare reports 12-month data showing lotivibart maintains viral suppression in ultra long-acting HIV regimen

    ViiV Healthcare, the global specialist HIV company majority owned by [...]

    February 27, 2026
  • Artificial Intelligence,Drug discovery,Precision medicine,Research & Development

    Promise Bio launches grant to support translational epiproteomics in biotech research

    Promise Bio has launched the Frontier Epiproteomic Innovation Grant, providing [...]

    February 24, 2026
  • Central Nervous System,Clinical Development,Clinical Trials,Drug Development,FDA,Pharmaceuticals and therapeutics,Precision medicine,Research & Development

    Alto Neuroscience completes Phase 2 enrollment for ALTO-101 in cognitive impairment associated with schizophrenia

    Alto Neuroscience has completed patient enrollment in its Phase 2 [...]

    February 13, 2026
  • Healthcare leadership,Market Access & Commercialization,Oncology,Patient Centricity,Precision medicine

    UK national cancer plan aims to boost survival and cut inequalities in diagnosis and treatment

    The UK Government this World Cancer Day has published its [...]

    February 4, 2026
  • Clinical Development,Clinical Trials,Oncology,Pharmaceuticals and therapeutics,Precision medicine,Research & Development

    Molecular Partners shares first patient imaging and dosimetry results for new cancer radiotherapy

    Molecular Partners has presented first patient imaging and dosimetry data [...]

    February 2, 2026
  • Clinical studies,Drug Development,Oncology,Precision medicine,Research & Development

    Nine-gene signature linked to lapatinib resistance in HER2-positive breast cancer

    Researchers at City St George’s, University of London have identified [...]

    January 29, 2026
  • Drug Development,FDA,Movers & Shakers,Precision medicine,Research & Development

    VoxCell appoints chief commercial officer as demand grows for predictive non-clinical models

    VoxCell, a Canadian biotechnology company developing vascularized 3D tissue models, [...]

    January 27, 2026
  • Diagnostics,Facilities and infrastructure,Oncology,Precision medicine,Research & Development

    Vortex Biotech opens new laboratory at Manchester Science Park to expand liquid biopsy development

    Vortex Biotech Holdings has opened a new laboratory facility at [...]

    January 27, 2026
  • Artificial Intelligence,Biotech,Clinical Trials,Diagnostics,Oncology,Precision medicine,Research & Development,Technology and platforms

    SpotitEarly announces strategic partnership with Fox Chase Cancer Center to advance early cancer detection

    SpotitEarly has formed a strategic partnership with Fox Chase Cancer [...]

    January 21, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Genmab appoints Margarida Duarte as general manager for Europe and emerging markets
    Categories: Healthcare leadership, Mergers & Acquisitions, Movers & Shakers, Pharmaceuticals and therapeutics
  • Opella appoints former Reckitt executive Gonzalo Balcazar to lead Europe and Latin America
    Categories: Healthcare leadership, Market Access & Commercialization, Movers & Shakers, Pharmaceuticals and therapeutics, Startups and innovations
  • Orano Med appoints Frederic Desdouits as CEO to advance targeted alpha therapy pipeline
    Categories: Biotech, Healthcare leadership, Movers & Shakers, Oncology, Pharmaceuticals and therapeutics, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top